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ABSTRACT: The expansion of electrochemical sensors to biomedical applications at point of care requires these sensors to under-
go analysis without any pre-treatment of extraction. This poses a major challenge for all electrochemical sensors including electro-
chemiluminescent (ECL) based sensors. ECL offers many advantages for biomedical applications however; obtaining results from 
complex matrices has proven to be a large hurdle for the application of ECL sensors within this field. This work demonstrates the 
potential of cathodic ECL to detect and quantify homocysteine with 0.1 nM limit of detection, which is associated with hyperhomo-
cysteinemia, in blood. This near infrared quantum dot (NIR QD) based ECL sensor displays good linearity allowing for rapid detec-
tion and providing a basis for exploitation of ECL based sensors for biomedical diagnostics utilising homocysteine as a model ca-
thodic co-reactant. This work will lay the foundations for future developments in biosensing and imaging fields and stands as an 
initial proof of concept for the utilization of cathodic ECL technologies for biomedical applications once the limits of detection 
within clinically relevant levels has been achieved. This work illustrates the potential of cathodic ECL sensors, using Hcy as a 
model complex, for the detection of biomolecules. 
Due to the ability of near infrared quantum dots (NIR QDs) 
to produce detectable ECL signals within blood thus minimis-
ing the issue of tissue auto-fluorescence has expanded the 
range of potential applications within the arena of biomedical 
diagnostics.1,2 Due to the presence of haemoglobin, the absorp-
tion spectrum of whole blood has presented a major hurdle for 
the exploitation of ECL based sensors.3 Typically, blood has 
an absorbance maxima at 420 and 540 nm with a minimum at 
~805 nm.4 NIR QDs with emissions above 805 nm therefore 
will have significantly less quenching within blood samples. 
This illustrates the promise NIR QDs present for exploitation 
within ECL biosensors5-7 with the potential for direct analysis 
within complex biological matrices including blood. This 
study will undertake initial examinations into the cathodic 
ECL behaviour and performance of NIR QDs in blood. As 
such, there is a clear requirement for examination of these 
properties to showcase the applicability of this type of electro-
chemical systems for use in biological samples. 
Homocysteine (Hcy) is an -amino acid that is formed in vi-
vo through metabolism of methionine. Typical blood Hcy lev-
els are up to 15 M, with concentrations above this resulting 
in hyperhomocysteinemia.8 Hyperhomocysteinemia has been 
linked with pulmonary embolism, stroke, and deep vein 
thrombosis and ischaemic heart disease.9-12 This is because 
Hcy and its cyclic metabolite homocysteine thiolactone modi-
fy the behaviour of endothelial cells, which can promote vas-
cular injury as their surface becomes a pro, rather than anti-
coagulant.13,14 They also promote platelet aggregation15 and 
oxidative stress due to the reactivity of the sulfhydryl group.16 
Detection of homocysteine tends to be via fluorescence cou-
pled to high-performance liquid chromatography,17,18 electro-
chemical,19 or colorimetric methods.20 There are currently no 
methods for the detection of Hcy directly from blood samples 
or using ECL as the detection method. Hcy contains a sulfhy-
dryl group, which are potent radical quenchers21,22 and so it 
was proposed that detection of Hcy could be accomplished 
through monitoring a decrease in ECL intensity. Here we re-
port on the proof of concept for the potential application of 
cathodic ECL detection in blood without the need for pre-
treatment or extraction, using Hcy as a model cathodic bi-
omarker. We have used Hcy to highlight the new potential 
avenues for electrochemical sensors. 
EXPERIMENTAL 
Materials  
Qdot® 800 ITK™ organic quantum dots, (1 μM in decane) 
were obtained from Invitrogen. Lumidot™ 560 and 640 nm 
QDs, (5 mg/mL in toluene), chitosan (medium molecular 
weight, 75 - 85 % de-acetylated), and all other chemicals were 
purchased from Sigma-Aldrich. All solutions were prepared in 
milli-Q water (18 mΩ cm).  
Bovine whole blood samples utilised within this study were 
obtained from Wishaw Abattoir Ltd following University of 
Strathclyde ethical approval. These were stored in aliquots at -
20 ºC. Aliquots were defrosted at room temperature on the day 
of analysis and used immediately. 
Instrumentation  
A CH instrument model 760D electrochemical analyser us-
ing a standard 3 electrode set-up including a 3 mm diameter 
GC working electrode, Pt wire counter electrode and Ag/AgCl 
3 M KCl reference electrode purchased from IJ Cambria Sci-
entific Ltd (UK) was utilised to record all electrochemical 
measurements. GC electrodes were cleaned following the pro-
 cedures outlined previously by Stewart et. al.23 A scan rate of 
100 mV s-1 and sample interval of 1 mV across a potential 
range outlined in each figure was used throughout this work. 
ECL and electrochemical responses were recorded using a CH 
instrument model 760D connected to a Hamamatsu H10723-
20 PMT which had a wavelength range of 230 to 920 nm. The 
PMT was biased at ±5 V. All electrochemical experiments 
were carried out within a light-tight Faraday cage in such as 
manner as to have the PMT window positioned directly below 
the GC electrode at room temperature. 
Preparation of CdSeTe/ZnS core-shell QD-chitosan 
composite film 
CdSeTe/ZnS QDs were prepared as described previously by 
Stewart et. al.23-25 3 μL of 1:1 (v/v) solution of QDs and chi-
tosan were drop-cast onto the working electrode surface and 
dried in the fridge for 1 h in the dark. As a control, a film con-
taining bare QDs in water was examined. QD concentration in 
the film was altered by mixing the water-soluble QDs with a 
suitable volume of water prior to mixing in a 1:1 (v/v) ratio 
with chitosan.26 These QDs were stable over a period of 3 
months and the composite films were stable over multiple 
scans. 
Preparation of samples 
Hcy samples ranging from 1 to 60 mM Hcy were prepared in 
1 mM K2S2O8 in 0.1 M PBS. Blood samples were spiked with 
Hcy to obtain final concentrations of Hcy in blood ranging 
from 1 to 6 mM. Blood samples containing 1 mM K2S2O8 in 
0.1 M PBS were prepared as previously outlined.23  
RESULTS AND DISCUSSION 
Electrochemical characterization  
The electrochemical behaviour of these QD modified elec-
trodes was interrogated via cyclic voltammetry (CV). Figure 1 
(a) shows the cathodic voltammograms from CV of a blank 
electrode and a QD/chitosan film in blood. Blank GC elec-
trode exhibits a single, small irreversible reduction peak at -
0.35 V, consistent with reduction of dissolved O2.
27 The 
QD/chitosan film voltammogram also contains this peak, with 
two further reduction processes at -1.15 and -1.85 V. The peak 
at -1.15 V has not been seen previously (in buffered aqueous 
solutions), which suggests that it is related to both the QDs 
and a species within solution. Whole blood contains a variety 
of species including proteins, carbohydrates and hormones that 
are potentially redox active and could interact with the posi-
tively charged QDs.28 This peak increases as the QD concen-
tration rises, confirming this peak is directly related to a reduc-
tion process involving the QDs (See Supplementary Figure 
S1). The occurrence of this reduction peak only in the pres-
ence of a QD/chitosan film in blood suggests the process is 
dependent upon interaction between a species in solution and 
the QDs. This may be the reduction of a species in blood that 
is catalysed by QDs or reduction of a QD bioconjugate that 
forms following immersion of the QD/chitosan film in blood. 
The peak at -1.85 V is consistent with that in buffered aqueous 
solutions25,29,30 and is therefore related to a secondary reduc-
tion process of the QDs. The slight shift in peak potential is 
related to the poorer electrochemical environment of blood 
compared to a buffered solution, which will have an impact on 
the transfer of electrons at the electrode surface and hinder 
reduction.  
This data indicates that the cathodic electrochemical behav-
iour of these QD composite films in blood is comparable to 
results obtained in PBS indicating the electrochemistry is not 
influenced substantially by this complex biological matrix at 
the potentials being examined in this study. 
 
Figure 1: (a) The black dashed line shows the typical CV re-
sponse of an unmodified GC electrode and the red line represents 
the electrochemical response of the 800 nm QD/chitosan compo-
site film in blood at a scan rate of 100 mV s-1 over the potential 
range -2.00 ≤ ν ≤ 0.00 V vs Ag/AgCl. (b) ECL signals recorded 
simultaneously with the traces from (a). 
NIR QD cathodic ECL response in blood  
Previous work has shown intense ECL signals can be ob-
tained using NIR QDs in buffered solutions and that oxidative 
ECL can be attained in blood.23,31 The detection of NIR QDs 
for cathodic ECL has not been achieved or examined directly 
from whole blood, and so investigation of this process was 
required to confirm a detectable signal was produced and that 
this signal was sensitive to changes in the system. The ad-
vantage of cathodic ECL is that it opens up the possibility of 
detecting additional analytes which do not undergo any anodic 
electrochemistry or ECL, thereby increasing the potential 
number of applications to which ECL systems can be applied. 
The occurrence of a cathodic ECL response from NIR QDs 
in blood with no additional co-reactants was first investigated. 
This was to determine whether any alteration in ECL behav-
iour was occurring through interactions with any species pre-
sent within a blood sample. The detected response of the QDs 
in blood is shown in Figure 1 (b). No ECL signal is observed 
in the absence of QDs indicating that there are no ECL active 
emitters in the blood sample within the cathodic region exam-
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 ined. Immobilisation of the QD/chitosan film on the electrode 
surface generates a small reduction peak upon potential scan-
ning at -1.00 V, as shown in Scheme 1. This compares to re-
duction peaks at -1.00 and -1.35 V when the same films are 
run in PBS, as shown in Figure S1.  
 
Scheme 1: A schematic representation of the electrochemical 
processes occurring to produce the ECL and quenched ECL re-
sponse in the absence and presence of Hcy. 
When analysed in PBS solution, reactive oxygen species 
(ROS) are expected to act as the co-reactant within the system. 
ROS are created through the oxygen reduction reaction 
(ORR), which has three common routes.17 The favoured path-
way is determined predominantly by the electrode material, 
electrolyte and the catalyst, in this case the QDs. GC elec-
trodes are known to catalyse 2-electron reductions via a com-
plex process that comprises a number of transient intermediate 
species.17 A variety of these are likely to be involved in the 
ECL pathways of the two peaks observed in PBS.17,32,33 
This was confirmed through the observation of a significant 
loss in signal intensity following sample de-aeration (See Sup-
plementary Figure S1). Determination of peak specific ROS 
acting as co-reactant was attempted through the addition of 
thiourea, a free radical scavenger with particular activity to-
wards hydroxyl radicals, and superoxide dismutase (SOD).34,35  
The appearance of a peak at -1.0 V in both blood and PBS 
dictates the same ECL processes are occurring and that blood 
constituents are not affecting the mechanism of ECL produc-
tion at this potential. As stated, the ECL mechanism of re-
sponse at this potential involves the interaction between re-
duced QDs and non-radical products of the ORR. A loss of 
signal intensity in blood is likely due to reactions of these non-
radical species with molecules in blood, such as the consump-
tion of OH- by H2CO3 to form HCO3
-, which is an essential 
reaction for maintenance of blood pH.36 A minimal degree of 
light absorption and scattering by blood will also occur as its 
absorbance in the NIR region is not zero.4,23 
The loss of ECL signal at -1.35 V in blood indicates that the 
OH• is not present at sufficient concentrations to elicit a de-
tectable ECL response. This is most probably caused by 
quenching of the radical by a species in blood. As OH• for-
mation is dependent upon O2 followed by H2O2 reduction, its 
concentration in solution will already be very low, so any 
quenching results in this complete loss of response. As ex-
pected, the lifetime of radical species, and therefore the con-
centration available for QD hole injection, appears to decrease 
in blood due to the presence of free radical scavengers (such 
as uric acid and glutathione).25,37,38 
However, the detection of an ECL response directly from 
blood, even without an additional co-reactant and with radical 
quenching taking place, was a significant discovery and instils 
considerable confidence in the capacity of NIR QDs to gener-
ate a detectable ECL signal from within a blood sample. En-
hancement of this ECL signal was previously shown via the 
addition of an K2S2O8 co-reactant to the blood sample and was 
comparable to that observed in the K2S2O8 – PBS system, as 
seen in Supplementary Figure S1.  
 
Figure 2: A typical ECL signal observed for a 800 nm 
QD/chitosan composite film obtained from a blood sample spiked 
with 1 mM K2S2O8 at a scan rate of 100 mV s-1 over the potential 
range -1.60 ≤ ν ≤ -0.60 V vs. Ag/AgCl and the linear relationship 
of this response with [K2S2O8] in blood (inset). 
Compared to the PBS response, there is a small shift in peak 
potential caused by slower electron transfer within blood. Alt-
hough radical quenching will still occur in blood, there is 
clearly still a sufficient concentration of SO4
•- within the ECL 
active zone to allow for the production of an intense ECL sig-
nal with the QDs. The rapid electron transfer kinetics of this 
system, a consequence of the high standard reduction potential 
of the SO4
•-/SO4
2- couple,25,39 will help minimize any interfer-
ence due to the free radical scavengers within blood. Determi-
nation of the responsiveness of this ECL signal to changes in 
SO4
•- concentration was examined through spiking of blood 
samples with an increasing concentration of K2S2O8 (Figure 
2). This shows a linear dependence of ECL response with 
K2S2O8 concentration in blood. 
This data shows the enhancement of NIR QD ECL in blood 
through addition of a suitable co-reactant (K2S2O8). This con-
firms that strong QD ECL emission in the NIR region can be 
produced directly in blood samples and that it is responsive to 
a small reactive molecule (SO4
•- in this case). This was a very 
promising result as it highlighted the ability of NIR QDs to 
detect a species within blood that was very likely involved in a 
number of competing reactions with alternative molecules in 
the system. Detection from blood will always be affected by 
these competing reactions due to the presence of naturally-
occurring interferents and so the ability of NIR QDs to detect 
this molecule in blood provided great confidence in their bio-
sensing ability in such conditions.  
NIR vs visible region ECL - Light penetration through 
blood 
A major benefit of NIR QDs over visible region QD ECL 
materials is their capacity for NIR emission. The results shown 
in this study have illustrated that a strong ECL signal can be 
generated and detected directly from blood using these NIR 
QDs. However, investigations have yet to be carried out to 
determine whether this response is superior to that generated 
from visible region QDs.  
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 Figure 3:  ECL dependence of 800 nm (blue dotted line), 640 nm 
(red dashed line) and 560 nm (black line in inset) QD/chitosan 
films over the potential range -2.00 ≤ ν ≤ 0.00 V vs. Ag/AgCl 
observed in a 1 mM K2S2O8 spiked blood sample in 0.1 M PBS. 
The penetration of detectable ECL light intensity through 
blood from 800, 640 and 560 nm QDs was examined. In the 
cathodic region, K2S2O8 was used as the co-reactant as it gen-
erated the strongest ECL emission. This showed a similar 
trend to those obtained for anodic ECL23 as illustrated in Fig-
ure 3 and Table 1. The emission maximum for these QDs was 
800 nm, however, the ECL emission was slightly shifted to 
805 nm which has previously been observed for surface con-
fined ECL luminophores.21,23,26,40 
Table 1: Reduction potentials and corresponding ECL intensi-
ties of 800, 640, and 560 nm QDs in blood containing 1 mM 
K2S2O8.  
QD emission  / 
nm 
Epc / V. vs 
Ag/AgCl 
ECL Intensity / 
A.U. 
800 -1.15 9299 
640 -1.35 897 
560 -1.65 58 
 
In the cathodic region, the potential of maximum intensity 
follows the expected trend of decreasing potential as QD size 
deceases (and therefore energy of the lowest unoccupied mo-
lecular orbital (LUMO) increases). An ECL signal is seen with 
all QDs, however, the detected response from the 800 nm QDs 
is significantly more intense than that for the 640 or 560 nm 
QDs (10 and 160 times more intense respectively) for the 
same QD concentration. The detected response from the 640 
nm QDs is 15 times more intense than that from the 560 nm 
QDs. These results indicate that as the wavelength of emitted 
light increases, the penetrability of this light through blood 
also increases. This is in line with the optical absorption of 
whole blood, which decreases with increasing wavelength, 
reaching a minimum at approximately 800 nm.4,41 This illus-
trates the capacity of NIR QD based cathodic ECL for direct 
analysis within complex biological matrices such as blood. 
Overall these results have shown that cathodic NIR QD ECL 
in blood is sensitive to addition of a small, reactive molecule, 
producing a strong enhancement in ECL intensity. The intense 
signal obtained with the NIR QD - K2S2O8 system in blood 
suggests that direct detection of low concentration analytes in 
blood could be possible using this system. Therefore, this 
work provides the groundwork for development of cathodic 
NIR QD ECL biosensors for direct analysis within complex 
biological matrices including blood. The ECL responses of 
this system towards other related species in blood has been 
inspected. This included uric acid, ascorbic acid, glucose, urea 
and citric acid. All of these produced an ECL response but 
only for anodic ECL and therefore did not interfere with the 
response for this current system. 
Response variability  
The inter-sample response variability was investigated in or-
der to determine the effect of different blood samples on the 
ECL response (See Supplementary Figure S1). The average 
intra-sample relative standard deviation was 8.3 %. An inter-
sample relative standard deviation of 10.0 % was observed, 
which is within an acceptable range. This shows that the ECL 
behaviour of the NIR QDs is consistent across different blood 
samples. 
Homocysteine detection 
To illustrate the potential of the ECL systems and in particu-
lar these composite NIR QDs films for bioanalysis and detec-
tion in blood, we demonstrated the ability of this set-up to 
detect Hcy within blood samples. The influence of Hcy con-
centration on the ECL response of NIR QDs composite in PBS 
was first investigated. An ECL signal at -1.00 V is observed, 
which decreases in intensity as the concentration of Hcy in-
creases as shown in Figure 4, with a limit of detection of 0.232 
µM. The shift in reduction potential compared to blood (Fig-
ure 2) is associated with faster electron transfer between pre-
cursor species in PBS, as there are fewer interfering species 
present within the buffer compared with the blood sample. The 
capability of NIR QDs for the detection of homocysteine 
through cathodic ECL has therefore been exhibited within the 
buffered system. The same methodology could then be applied 
to blood samples with confidence.  
 
Figure 4:  Dependence of ECL signals from the QD composite 
films on the concentration of 20 µM to 4 mM Hcy in 1 mM 
K2S2O8 in 0.1 M PBS (black represents blank control) at 100 mV 
s-1 over the potential range -1.20 ≤ ν ≤ 0.00 V vs. Ag/AgCl. Inset 
shows the trend of maximum ECL signal at ~-1.00 V vs. Ag/AgCl 
for this data.  
ECL response mechanism of homocysteine 
Hcy inhibits the ECL signal through quenching of the radical 
precursor species, SO4
•- following equations 1 and 2.21,22 
𝑆𝑂4
  •− + 𝑅 − 𝑆𝐻 → 𝑅 − 𝑆• + 𝐻𝑆𝑂4
 −                              (1) 
2𝑅 − 𝑆• → 𝑅 − 𝑆 − 𝑆 − 𝑅                                                 (2) 
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 where R is CH2CH2CHNH2COOH. The sulfhydryl group of 
Hcy donates a proton to SO4
•- forming a radical thiol species 
(equation (1)), which rapidly dimerises (equation (2)). Alter-
natively, quenching of SO4
•- can occur via the carboxylic acid 
moiety of Hcy (equation (3) and (4)).42 
𝑆𝑂4
  •− + 𝑅 − 𝐶𝑂𝑂𝐻 + 𝑂2 → 𝑅 − 𝐶𝑂𝑂
• + 𝐻𝑆𝑂4
 −       (3) 
𝑆𝑂4
  •− + 𝑅 − 𝐶𝑂𝑂− → 𝑅 − 𝐶𝑂𝑂• + 𝑆𝑂4
 2−                   (4) 
where R is CHNH2CH2CH2SH. In equation 3 a proton is ab-
stracted from the C-H bond forming a carboxyl radical and 
bisulfate anion. Carboxyl radicals can also be formed through 
oxidation of the carboxylate anion by SO4
•- (equation (4)). It is 
likely that each of these processes contribute to the quenching 
of SO4
•- and therefore reduction in the observed ECL signal, 
however, it is not clear which is the dominant process.  
As with our previous study, the relationship between ECL 
emission intensity and quencher was expressed by the Stern-
Volmer equation (5). 40,43,44  
𝐼0
𝐼
= 1 + 𝐾𝑆𝑉[𝑄]                                                              (5) 
The initial ECL intensity and the ECL intensity at a known 
concentration of the quencher [Q] are represented by I0 and I, 
while the Stern-Volmer quenching constant is represented by 
KSV. The data obtained here did not exhibit a linear depend-
ence as predicted by the Stern-Volmer equation, as is evident 
from the data in Figure 4 (See Supplementary Figure S2). As 
the quenching process can be affected by surface confinement 
within a polymer film,26,45-47 the Hindered Access Model was 
utilised to account for this within this system. This considers 
the confinement of the QDs and SO4
•- within the chitosan film, 
taking into consideration the differences in accessibility for 
different species to the quencher molecules within the film. 
The Hindered Access Model predicts (I0/I0 - I) and (1/[Q]) 
have a linear correlation, which results in an intercept equal to 
fa
-1 and a slope of faKa
-1(equation (6)),44  
𝐼0
𝐼0 − 𝐼
=
1
𝑓𝑎
+
1
𝑓𝑎𝐾𝑎[𝑄]
                                                    (6) 
Where fa is the fraction of accessible species and Ka is the 
Stern-Volmer quenching constant of this accessible fraction. 
This modified model has previously23 been shown to predict 
an influence of the chitosan polymer on the quenching behav-
iour as observed in the system (See Supplementary Figure S2). 
A linear dependence between 20 µM and 4 mM is observed, 
with a corresponding Ka value of 1.3x10
3 M-1 s-1. This, in ef-
fect, represents the linear range of the sensor and has been 
used as the standard curve for Hcy detection with a limit of 
detection of 0.1 nM. This is considerably higher than sensitivi-
ties observed for alternative ECL based systems.6,48,49 Howev-
er, it should be noted that these limits of detection were 
achieved in idealised sample matrices and not in complex bio-
logical matrices. 
 The influence of chitosan on the quenching behaviour was 
confirmed as a film of bare QDs followed a typical Stern-
Volmer relationship (Figure S2), yielding a linear dependence 
of I0/I on [Q]. 
Analytical Performance  
Commonly exiting species likely to interfere with the selec-
tivity of this system were examined. These included ascorbic 
acid, citric acid and uric acid. These are commonly encoun-
tered species within blood samples, and as such were used to 
evaluate the clinical viability and cross-reactivity of this sys-
tem with the responses shown in Figure 6. None of these had 
any significant impact on the observed cathodic ECL response 
indicating good sensor specificity. It is important to note that 
these species did produce an anodic ECL response but this did 
not interfere with the cathodic ECL response monitored for 
Hcy detection. 
Figure 5: (a) ECL signal of 800 nm QD/chitosan film in 1 
mM K2S2O8 in blood (black) following additions of 0.025 to 6 
mM Hcy recorded at 100 mV s-1 over the potential range -1.40 
≤ ν ≤ 0.00 V vs. Ag/AgCl. Inset shows the maximum ECL 
signal of 800 nm composite QD/chitosan film in these solu-
tions at ~-1.15 V vs. Ag/AgCl. (b) Hindered Access Model 
plot of 800 nm QD/chitosan film in 1 mM K2S2O8 in blood 
with increasing [Hcy]. The ECL profiles of all these results are 
shown in supplementary material (Figure S3).  
However, cysteine, cystine and methionine do interfere with 
the detection of Hcy to different extents. All of these mole-
cules are structurally similar to Hcy and undergo similar elec-
trochemical processes. However, their responses were still 
significantly less than that of Hcy. To realise selectivity, im-
provements in the current strategy need to be developed to 
realise real world applications at the desired concentrations. 
This might include incorporating other materials or using a 
microfluidic system to remove interferents prior to analysis in 
the time scale required for detection. 
Figure 6. Cathodic ECL signal dependence observed at -1.15 
V for the 800 nm QD/chitosan composite film in whole blood 
(WB) with 1 mM K2S2O8 with 0.25 mM Hcy (orange), (37.5 
M dopamine (Dop, red)), ascorbic acid (blue), citric acid 
(purple) at 5 mM and 10 mM respectively as well as cysteine 
(Cys), cystine and methionine (Met, black) at 10 mM. Error 
bars represent triplicate data points. 
As Hcy had the ability to quench NIR QD ECL in buffer, the 
same investigation was carried out in blood samples. The ECL 
response in blood spiked with increasing Hcy concentrations is 
shown in Figure 5 (a), with minor deviations due to extremely 
low levels of Hcy in the blood samples expected. The results 
correlated well with high-performance liquid chromatography 
(HPLC) data obtained for these samples. Indeed, the percent-
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 age recoveries for these samples was found to be ≤± 5 % com-
pared to chromatographic analysis undertaken on the same 
samples as illustrated in Table 2. Some of the discrepancies in 
the responses maybe due to the presence of interferents such 
as cysteine, cystine or methionine. Supplementary Figure S4 
shows a typical response from the chromatographic analysis 
obtained. 
The profile contains an ECL peak at approximately -1.15 V, 
which decreases in intensity as Hcy concentration increases. 
Movement of this reduction peak suggests that interference 
between precursor species and constituents in whole blood are 
affecting electron transfer at the electrode surface. The modi-
fied Stern-Volmer plot (Figure 5 (b)) yields a linear relation-
ship between 0.05 and 6 mM Hcy, with a Ka value of 1.4x10
2 
M-1 s-1.  
This quenching rate is ~12 times slower than that achieved 
with Hcy in PBS (See Supplementary Figure S2), indicating 
that constituents in blood are influencing the quenching pro-
cess and explaining the linear relationship between ECL inten-
sity and [Hcy] observed in blood but not PBS (Figures 4 and 
5(a)). This is likely due to the formation of electrostatic inter-
actions between the amine and/or carboxylic acid moieties of 
Hcy with charged regions of biomolecules (such as albumin) 
in blood. This will reduce Hcy quenching efficiency as diffu-
sion of this bulkier complex through chitosan will be hindered 
and therefore its rate of reaction with SO4
•- at the electrode 
surface will decrease. The Ka in both buffer and blood does 
not currently allow detection down to clinically relevant lev-
els, however, it is hoped that improvements in biosensor per-
formance would permit this. However, comparison with a 
chromatographic technique showed comparable results indi-
cating that there is potential for this technology to be utilised 
once the issues of sensitivity have been addressed.   
Table 2. Comparison of HPLC results for Hcy concentration 
determination to those obtained with this ECL based system 
for unknown blood serum samples and the corresponding % 
recoveries. 
“Unknown” 
Conc. / mM 
Averaged 
Cal. Conc. / 
mM 
HPLC Av-
eraged 
Calc. Conc. 
/ mM 
% Recover-
ies 
1.00 1.03 1.06 97.2 
3.00 2.98 3.03 98.4 
6.00 6.02 6.10 98.7 
 
CONCLUSION 
This work has shown the applicability of co-reactant NIR 
QD ECL for the detection of a clinically relevant analyte with-
in blood. Hcy was used as a model complex to highlight the 
potential of ECL sensors to be applied to this type of analysis 
as a proof of concept for ECL technology. Although this sys-
tem did not achieve the high sensitivities or the required selec-
tivity obtained in other electrochemical systems or indeed to 
current analytical methods for Hcy detection, it does illustrate 
the capacity of ECL based sensors to detect analytes in blood 
without the need for complex sample extraction, thereby re-
ducing the amount of sample preparation required and high-
lighting the expansion of ECL applications into the detection 
of analytes which undergo cathodic electrochemistry in blood. 
Significantly, this is the first example of a cathodic ECL bio-
sensor capable of detecting a target analyte directly in blood. 
This illustrates the capacity for exploitation of ECL based 
sensors within biomedical applications. It illustrates the poten-
tial of ECL biosensors to effectively detect a medically rele-
vant biomarker directly in complex biological matrices with-
out any sample pre-treatment. Future work will be undertaken 
to enhance the sensitivities and selectivities and to allow for 
multiplexed detection and analysis.  
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the interferents given in Figure 6 (Figure S3). Chromatographic 
experimental details are also included (Figure S4). This material 
is available free of charge via the Internet at http://pubs.acs.org. 
AUTHOR INFORMATION 
Corresponding Author 
* lynn.dennany@strath.ac.uk 
Author Contributions 
The manuscript was written through contributions of all authors. 
ACKNOWLEDGMENT  
The authors would like to acknowledge funding from the EU FP7 
funding through the Marie Curie Reintegration Grant scheme 
(PIRG-2010-268236), which has supported this work. LD and KB 
would also like to acknowledge The Carnegie Trust for PhD 
scholarship funding. 
REFERENCES 
(1) Xie, W.; An, X.; Chen, L.; Li, J.; Leng, J.; Lǚ, W.; Zhang, L.; 
Luo, Y. Tunable phase and upconverting luminescence of Gd3+ co-
doped NaErF4:Yb3+ nanostructures. Mater. Res. Bull. 2017, 95, 509-
514. 
(2) Chatterjee, D. K.; Rufaihah, A. J.; Zhang, Y. Upconversion 
fluorescence imaging of cells and small animals using lanthanide 
doped nanocrystals. Biomaterials 2008, 29, 937-943. 
(3) Wray, S.; Cope, M.; Delpy, D. T.; Wyatt, J. S.; Reynolds, E. O. 
R. Characterization of the near infrared absorption spectra of 
cytochrome aa3 and haemoglobin for the non-invasive monitoring of 
cerebral oxygenation. Biochim. Biophys. Acta, Bioenerg. 1988, 933, 
184-192. 
(4) Roggan, A.; Friebel, M.; Doerschel, K.; Hahn, A.; Mueller, G. 
J.; SPIE, 1999, p 11. 
(5) Liu, X.; Jiang, H.; Fang, Y.; Zhao, W.; Wang, N.; Zang, G. 
Quantum Dots Based Potential-Resolution Dual-Targets 
Electrochemiluminescent Immunosensor for Subtype of Tumor 
Marker and Its Serological Evaluation. Anal. Chem. 2015, 87, 9163-
9169. 
(6) Li, S.-K.; Chen, A.-Y.; Niu, X.-X.; Liu, Z.-T.; Du, M.; Chai, 
Y.-Q.; Yuan, R.; Zhuo, Y. In situ generation of 
electrochemiluminescent DNA nanoflowers as a signal tag for mucin 
1 detection based on a strategy of target and mimic target 
synchronous cycling amplification. Chem. Commun. 2017, 53, 9624-
9627. 
(7) Yang, H.; Zhang, Y.; Li, L.; Zhang, L.; Lan, F.; Yu, J. Sudoku-
like Lab-on-Paper Cyto-Device with Dual Enhancement of 
Electrochemiluminescence Intermediates Strategy. Anal. Chem. 2017, 
89, 7511-7519. 
 (8) Skibińska, E.; Sawicki, R.; Lewczuk, A.; Prokop, J.; Musiał, 
W.; Kowalska, I.; Mroczko, B. Homocysteine and progression of 
coronary artery disease. Kardiol Pol 2004, 60, 197-205. 
(9) Boushey, C. J.; Beresford, S. A.; Omenn, G. S.; Motulsky, A. 
G. A quantitative assessment of plasma homocysteine as a risk factor 
for vascular disease: Probable benefits of increasing folic acid intakes. 
JAMA 1995, 274, 1049-1057. 
(10) Clarke, R.; Collins, R.; Lewington, S.; Donald, A.; Alfthan, 
G.; Tuomilehto, J.; Arnesen, E.; Bonaa, K.; Blacher, J.; Boers, G. H. 
J.; Bostom, A.; Bots, M. L.; Grobbee, D. E.; Brattström, L.; Breteler, 
M. M. B.; Hofman, A.; Chambers, J. C.; Kooner, J. S.; Coull, B. M.; 
Evans, R. W.; Kuller, L. H.; Evers, S.; Folsom, A. R.; Freyburger, G.; 
Parrot, F.; Genest, J., Jr.; Dalery, K.; Graham, I. M.; Daly, L.; 
Hoogeveen, E. K.; Kostense, P. J.; Stehouwer, C. D. A.; Hopkins, P. 
N.; Jacques, P.; Selhub, J.; Luft, F. C.; Jungers, P.; Lindgren, A.; 
Lolin, Y. I.; Loehrer, F.; Fowler, B.; Mansoor, M. A.; Malinow, M. 
R.; Ducimetiere, P.; Nygard, O.; Refsum, H.; Vollset, S. E.; Ueland, 
P. M.; Omenn, G. S.; Beresford, S. A. A.; Roseman, J. M.; Parving, 
H. H.; Gall, M. A.; Perry, I. J.; Ebrahim, S. B.; Shaper, A. G.; 
Robinson, K.; Jacobsen, D. W.; Schwartz, S. M.; Siscovick, D. S.; 
Stampfer, M. J.; Hennekens, C. H.; Feskens, E. J. M.; Kromhout, D.; 
Ubbink, J.; Elwood, P.; Pickering, J.; Verhoef, P.; Von Eckardstein, 
A.; Schulte, H.; Assmann, G.; Wald, N.; Law, M. R.; Whincup, P. H.; 
Wilcken, D. E. L.; Sherliker, P.; Linksted, P.; Smith, G. D. 
Homocysteine and risk of ischemic heart disease and stroke: A meta-
analysis. JAMA 2002, 288, 2015-2022. 
(11) Danesh, J.; Lewington, S. Plasma Homocysteine and 
Coronary Heart Disease: Systematic Review of Published 
Epidemiological Studies. J Cardiovasc Risk 1998, 5, 229-232. 
(12) Wald, D. S.; Law, M.; Morris, J. K. Homocysteine and 
cardiovascular disease: evidence on causality from a meta-analysis. 
BMJ 2002, 325, 1202. 
(13) Karolczak, K.; Olas, B. Mechanism of action of homocysteine 
and its thiolactone in hemostasis system. Physiol. Res. 2009, 58, 623. 
(14) Perła-Kaján, J.; Twardowski, T.; Jakubowski, H. Mechanisms 
of homocysteine toxicity in humans. Amino Acids 2007, 32, 561-572. 
(15) Rajkumar, V.; Ragatzki, P.; Sima, A.; Levy, J. Enhanced 
platelet aggregation, high homocysteine level, and microvascular 
disease in diabetic muscle infaractions. Endocr. J 1999, 11, 57-60. 
(16) Stamler, J. S.; Osborne, J. A.; Jaraki, O.; Rabbani, L. E.; 
Mullins, M.; Singel, D.; Loscalzo, J. Adverse vascular effects of 
homocysteine are modulated by endothelium-derived relaxing factor 
and related oxides of nitrogen. J. Clin. Invest. 1993, 91, 308-318. 
(17) Song, H.; Zhang, J.; Wang, X.; Zhou, Y.; Xu, C.; Pang, X.; 
Peng, X. A novel “turn-on” fluorescent probe with a large stokes shift 
for homocysteine and cysteine: Performance in living cells and 
zebrafish. Sens. Actuators, B 2018, 259, 233-240. 
(18) Zhang, Y.; Yao, W.; Liang, D.; Sun, M.; Wang, S.; Huang, D. 
Selective detection and quantification of tryptophan and cysteine with 
pyrenedione as a turn-on fluorescent probe. Sens. Actuators, B 2018, 
259, 768-774. 
(19) Xu, Q.; Yuan, H.; Dong, X.; Zhang, Y.; Asif, M.; Dong, Z.; 
He, W.; Ren, J.; Sun, Y.; Xiao, F. Dual nanoenzyme modified 
microelectrode based on carbon fiber coated with AuPd alloy 
nanoparticles decorated graphene quantum dots assembly for 
electrochemical detection in clinic cancer samples. Biosens 
Bioelectron 2018, 107, 153-162. 
(20) Xia, Y.; Zhang, H.; Zhu, X.; Zhang, G.; Yang, X.; Li, F.; 
Zhang, X.; Fang, M.; Yu, J.; Zhou, H. A highly selective two-photon 
fluorescent chemosensor for tracking homocysteine via situ reaction. 
Dyes Pigm. 2018, 155, 159-163. 
(21) Dennany, L.; Gerlach, M.; O'Carroll, S.; Keyes, T. E.; Forster, 
R. J.; Bertoncello, P. Electrochemiluminescence (ECL) sensing 
properties of water soluble core-shell CdSe/ZnS quantum dots/Nafion 
composite films. J. Mater. Chem. 2011, 21, 13984-13990. 
(22) O'Reilly, E. J.; Conroy, P. J.; Hearty, S.; Keyes, T. E.; 
O'Kennedy, R.; Forster, R. J.; Dennany, L. Electrochemiluminescence 
platform for the detection of C-reactive proteins: application of 
recombinant antibody technology to cardiac biomarker detection. RSC 
Adv. 2015, 5, 67874-67877. 
(23) Stewart, A. J.; Hendry, J.; Dennany, L. Whole Blood 
Electrochemiluminescent Detection of Dopamine. Anal. Chem. 2015, 
87, 11847-11853. 
(24) Woelfle, C.; Claus, R. O. Transparent and flexible quantum 
dot–polymer composites using an ionic liquid as compatible 
polymerization medium. Nanotechnology 2007, 18, 025402. 
(25) Russell, R.; Stewart, A. J.; Dennany, L. Optimising 
electrogenerated chemiluminescence of quantum dots via co-reactant 
selection. Anal. Bioanal. Chem. 2016, 408, 7129-7136. 
(26) Stewart, A. J.; O’Reilly, E. J.; Moriarty, R. D.; Bertoncello, 
P.; Keyes, T. E.; Forster, R. J.; Dennany, L. A Cholesterol Biosensor 
Based on the NIR Electrogenerated-Chemiluminescence (ECL) of 
Water-Soluble CdSeTe/ZnS Quantum Dots. Electrochim. Acta 2015, 
157, 8-14. 
(27) Bao, L.; Sun, L.; Zhang, Z.-L.; Jiang, P.; Wise, F. W.; Abruña, 
H. D.; Pang, D.-W. Energy-Level-Related Response of Cathodic 
Electrogenerated-Chemiluminescence of Self-Assembled CdSe/ZnS 
Quantum Dot Films. J. Phys. Chem. C 2011, 115, 18822-18828. 
(28) Lebedev, A. V.; Pelouch, V.; Ivanova, M. V.; Levitsky, D. O. 
AQuantitative Evaluation OfRedox-Active Compounds In Human 
Blood Lipids. Hemoglobin 2011, 35, 247-254. 
(29) Haram, S. K.; Quinn, B. M.; Bard, A. J. Electrochemistry of 
CdS Nanoparticles:  A Correlation between Optical and 
Electrochemical Band Gaps. J. Am. Chem. Soc 2001, 123, 8860-8861. 
(30) Chen, S.; Truax, L. A.; Sommers, J. M. Alkanethiolate-
Protected PbS Nanoclusters:  Synthesis, Spectroscopic and 
Electrochemical Studies. Chem. Mater. 2000, 12, 3864-3870. 
(31) Bertoncello, P.; Stewart, A. J.; Dennany, L. Analytical 
applications of nanomaterials in electrogenerated chemiluminescence. 
Anal. Bioanal. Chem. 2014, 406, 5573-5587. 
(32) Wang, Z.; Song, H.; Zhao, H.; Lv, Y. Graphene-amplified 
electrogenerated chemiluminescence of CdTe quantum dots for H2O2 
sensing. Luminescence 2013, 28, 259-264. 
(33) Devadoss, A.; Dennany, L.; Dickinson, C.; Keyes, T. E.; 
Forster, R. J. Highly sensitive detection of NADH using 
electrochemiluminescent nanocomposites. Electrochem. Commun. 
2012, 19, 43-45. 
(34) Wasil, M.; Halliwell, B.; Grootveld, M.; Moorhouse, C. P.; 
Hutchison, D. C. S.; Baum, H. The specificity of thiourea, 
dimethylthiourea and dimethyl sulphoxide as scavengers of hydroxyl 
radicals. Their protection of <em>α</em><sub>1</sub>-
antiproteinase against inactivation by hypochlorous acid. Biochem. J. 
1987, 243, 867-870. 
(35) Prasad, A. K.; Mishra, P. C. Scavenging of superoxide radical 
anion and hydroxyl radical by urea, thiourea, selenourea and their 
derivatives without any catalyst: A theoretical study. Chem. Phys. 
Lett. 2017, 684, 197-204. 
(36) Di Mascio, P.; Murphy, M. E.; Sies, H. Antioxidant defense 
systems: the role of carotenoids, tocopherols, and thiols. Am. J. Clin. 
Nutr. 1991, 53, 194S-200S. 
(37) Ames, B. N.; Cathcart, R.; Schwiers, E.; Hochstein, P. Uric 
acid provides an antioxidant defense in humans against oxidant- and 
radical-caused aging and cancer: a hypothesis. Proc. Natl. Acad. Sci. 
U.S.A. 1981, 78, 6858-6862. 
(38) Pippenger, C. E.; Browne, R. W.; Armstrong, D. In Free 
Radical and Antioxidant Protocols, Armstrong, D., Ed.; Humana 
Press: Totowa, NJ, 1998, pp 299-313. 
(39) Pettinger, B.; Schöppel, H. R.; Gerischer, H. 
Electroluminescence at semiconductor electrodes caused by hole 
injection from electrolytes. Ber. Bunsenges. Phys. Chem. 1976, 80, 
849-855. 
(40) Dennany, L.; Keyes, T. E.; Forster, R. J. Surface confinement 
and its effects on the luminescence quenching of a ruthenium-
containing metallopolymer. Analyst 2008, 133, 753-759. 
(41) O'Reilly, E. J.; Keyes, T. E.; Forster, R. J.; Dennany, L. 
Deactivation of the ruthenium excited state by enhanced 
homogeneous charge transport: Implications for 
electrochemiluminescent thin film sensors. Electrochem. Commun. 
2018, 86, 90-93. 
(42) Grgić, I.; Podkrajšek, B.; Barzaghi, P.; Herrmann, H. 
Scavenging of SO4− radical anions by mono- and dicarboxylic acids 
 in the Mn(II)-catalyzed S(IV) oxidation in aqueous solution. Atmos. 
Environ. 2007, 41, 9187-9194. 
(43) O'Reilly, E. J.; Dennany, L.; Griffith, D.; Moser, F.; Keyes, T. 
E.; Forster, R. J. Ground and excited state communication within a 
ruthenium containing benzimidazole metallopolymer. Phys. Chem. 
Chem. Phys. 2011, 13, 7095-7101. 
(44) Lakowicz, J. R. Principles of Fluorescence Spectroscopy; 
Springer US: Boston, MA, 2006, p 1-26. 
(45) Clements, J. H.; Webber, S. E. Fluorescence Quenching 
Kinetics of Anthracene Covalently Bound to Poly(Methacrylic Acid):  
Midchain Labeling. J. Phys. Chem. A 1999, 103, 2513-2523. 
(46) Deng, S.; Zhang, T.; Zhang, Y.; Shan, D.; Zhang, X. 
Chronopotentiometric synthesis of quantum dots with efficient 
surface-derived near-infrared electrochemiluminescence for 
ultrasensitive microchip-based ion-selective sensing. RSC Adv. 2014, 
4, 29239-29248. 
(47) Eckert, A. R.; Hsiao, J.-S.; Webber, S. E. Photophysics of 
Adsorbed and Solution Phase End-tagged Poly(ethylene oxide). J. 
Phys. Chem. 1994, 98, 12025-12031. 
(48) Xue, J.; Zhang, Z.; Zheng, F.; Xu, Q.; Xu, J.; Zou, G.; Li, L.; 
Zhu, J.-J. Efficient Solid-State Electrochemiluminescence from High-
Quality Perovskite Quantum Dot Films. Anal. Chem. 2017, 89, 8212-
8216. 
(49) Zhang, Y.; Li, L.; Zhang, L.; Ge, S.; Yan, M.; Yu, J. In-situ 
synthesized polypyrrole-cellulose conductive networks for potential-
tunable foldable power paper. Nano Energy 2017, 31, 174-182. 
 
  
  
9 
For TOC only 
 
 
 
